Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation

This post-market registry is designed to collect real world data on the use of the Globe PF System for the treatment of atrial fibrillation (AF).

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Key Inclusion Criteria:

Patients with a planned ablation procedure using the commercially available Globe PF System

Key Exclusion Criteria:

Patients whose life expectancy is 1 year or less
Contraindication to left atrial catheter ablation or PF ablation
Current enrollment in any investigational study of a medical device, biologic, or drug not pre-approved by Kardium

Treatment and study plan

Globe Pulsed Field System

Device

Ablation and atrial mapping with the Globe Pulsed Field System

Primary outcomes

Effectiveness endpoint

Time frame: 12 months

Rate of 12-month treatment success following ablation using the Globe PF System.
Safety endpoint

Time frame: 7 days

Rate of subjects with one or more major adverse events up to 7 days following the index ablation procedure.

Study contacts

Contact information is provided by the study sponsor or research team.

Clinical Affairs

CONTACT

[email protected]

+1 (604) 248 8891

Sponsors and collaborators

Lead sponsor

Kardium Inc.

Industry

Registry information

Important dates

Study start: 2026
Primary completion: 2029
Study completion: 2029
First posted: Jun 16, 2026
Registry last updated: Jun 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting